The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s atopic dermatitis market report forecasts the atopic dermatitis market size to grow to $13.06 Billion by 2027, with a CAGR (compound annual growth rate) of almost 15%.

Learn More On The Atopic Dermatitis Market Report 2023 – https://www.thebusinessresearchcompany.com/report/atopic-dermatitis-global-market-report

Atopic Dermatitis Market Size Forecast
The global atopic dermatitis market is expected to grow from $6.48 billion in 2022 to $7.51 billion in 2023 at a compound annual growth rate (CAGR) of 15.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The atopic dermatitis market is expected to grow to $13.06 billion in 2027 at a CAGR of 14.9%.

North America held the largest atopic dermatitis market share, and Asia-Pacific was the fastest-growing region in 2022.

Key Atopic Dermatitis Market Driver ­– Increase In The Prevalence Of Atopic Dermatitis
For instance, according to the National Eczema Association, a US-based organization working to spread awareness related to eczema, in 2021, 31.6 million people in the US had some form of eczema, which was about 10% of the total population. Approximately 9.6 million children under the age of 18 had atopic dermatitis, and 80% of the individuals were affected by dermatitis before the age of 6 years. Therefore, the increasing prevalence of atopic dermatitis is driving the growth of the atopic dermatitis market.

Request for A Sample Of The Global Atopic Dermatitis Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8285&type=smp

Key Atopic Dermatitis Market Trend – Product Innovations
Major companies in the market are introducing innovative products to strengthen their market position. For instance, in May 2020, Sanofi, a France-based pharmaceutical company, received FDA approval for its novel dupilumab drug Dupixent for the treatment of moderate-to-severe atopic dermatitis. It is the first and only biologic drug to receive approval for treating atopic dermatitis in children between the ages of 6 and 11. Children treated with it achieved clearer skin in just 16 weeks in the phase 3 trial, which was better than topical corticosteroids alone.

Atopic Dermatitis Market Segment
1) By Drug Class: Corticosteroids, Emollients/Moisturizers, IL-4 and PDE4 Inhibitors, Calcineurin Inhibitors, Antibiotics, Other Drug Classes
2) By Mode of Administration: Topical, Injectable, Oral
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Atopic Dermatitis Market Major Players and Strategies
Major players in the atopic dermatitis market are Sanofi S.A., Meda AB, Regeneron Pharmaceuticals Inc., Novartis International AG, Pfizer Inc., AbbVie Inc., Astellas Pharma Inc., Arcutis Biotherapeutics Inc., Asana Biosciences LLC, Dermavant Sciences Inc., Eli Lilly and Company, Galderma S.A., Incyte Corporation, Bayer AG, Bausch Health Companies Inc., Boehringer Ingelheim International GmbH, GlaxoSmithKline plc, and F. Hoffmann-La Roche AG.

In September 2022, Arcutis Biotherapeutics, a US-based commercial-stage biopharmaceuticals company, acquired Ducentis BioTherapeutics for an undisclosed amount. The acquisition would help Arcutis achieve its vision of leading the medical dermatology market and would help it develop medications for the unmet dermatological needs of its patients. Ducentis BioTherapeutics is a US-based preclinical-stage biotechnology company developing lead indications for atopic dermatitis.

The Atopic Dermatitis Global Market Report 2023 covers regional data on atopic dermatitis market size, atopic dermatitis market trends and drivers, opportunities, strategies, and atopic dermatitis market competitor analysis. The countries covered in the atopic dermatitis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Atopic dermatitis is a dermatological condition that causes dryness and itching of the skin. It is a chronic condition that progresses over time and is not spread by contact.

View More Reports Related To The Atopic Dermatitis Market –
Dermatology Medical Lasers Global Market Report 2023
Dermatitis Global Market Report 2023
Dermatology Devices Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: